KEYNOTE:
Submitting the eCTD to European Member States: Functionality, Processes, and Optimal Timelines for Regionally Wide Acceptance
Andrew P Marr, Director, e-Regulatory Development, Global Regulatory Operations, GLAXOSMITHKLINE

FEATURED PRESENTATIONS:
Moving from Data to Documents: The Next Stage for Global Submission Standards?
Donald Palmer, Associate Director, Regulatory Systems, MEDIMMUNE

Reviewing eCTD Timelines with a Focus on Effeciency and Capturing Current Metrics for Future Submission Opportunities
S. Albert Edwards, PharmD, RAC, Director, Regulatory Operations, TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER